India's second-largest hospital chain by revenue & EBITDA; 21 facilities, 6,000+ beds nationwide.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 537 | 966 | 970 | 971 | 972 | 972 | 972 | 973 |
| Reserves | 2.0k | 4.7k | 5.3k | 6.4k | 7.4k | 8.4k | 7.5k | 9.8k |
| Borrowings | 875 | 1.1k | 913 | 689 | 1.3k | 3.0k | 705 | 3.5k |
| Other Liabilities | 546 | 1.8k | 2.0k | 2.0k | 2.3k | 2.8k | 1.2k | 3.0k |
| Total Liabilities | 4.0k | 8.5k | 9.2k | 10.1k | 12.0k | 15.2k | 10.4k | 17.2k |
| AssetsFixed Assets | 851 | 6.5k | 7.0k | 7.0k | 8.8k | 11.5k | 4.9k | 13.0k |
| CWIP | 28 | 27 | 151 | 252 | 553 | 901 | 345 | 593 |
| Investments | 2.2k | 1 | 1 | 1 | 2 | 3 | 2.6k | 5 |
| Other Assets | 913 | 2.0k | 2.0k | 2.8k | 2.7k | 2.8k | 2.5k | 3.6k |
| Total Assets | 4.0k | 8.5k | 9.2k | 10.1k | 12.0k | 15.2k | 10.4k | 17.2k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 89 | 77 | 118 | 741 | 1.2k | 1.1k | 1.4k | 1.6k |
| Cash from Investing | -17 | -2.6k | 206 | -764 | -1.2k | -1.3k | -1.6k | -1.7k |
| Cash from Financing | -74 | 2.4k | 191 | -294 | -289 | -264 | -163 | 59 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -27 | -13 | 1 | 192 | 877 | 342 | 500 | 165 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (75.3×) and current (73.5×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 12.9% growth and a 73× exit, ₹1090 only delivers your return if you pay ₹866. The price is currently baking in 18% growth.
EPS grows 12.9%/yr for 5 years, then fades to 6% over 2, exits at 73×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 12.9% | 16.74 |
| FY28 | 12.9% | 18.90 |
| FY29 | 12.9% | 21.34 |
| FY30 | 12.9% | 24.09 |
| FY31 | 12.9% | 27.20 |
| FY32 | 9.4% ·fade | 29.77 |
| FY33 | 6.0% ·fade | 31.56 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.